Efficacy and Safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening
Status:
Recruiting
Trial end date:
2022-12-15
Target enrollment:
Participant gender:
Summary
The purpose is to test the hypothesis that microdrop instillation of combined phenylephrine
1.67% and tropicamide 0.33% eyedrops causes at least equal mydriasis compared with standard
drop instillation of the same mydriatic regimen, which constitutes routine care for pupil
dilation during retinopathy of prematurity (ROP) screening in our neonatal intensive care
unit. Comparison, also, will be made to the subsequent adverse events and the drug
concentration in peripheral blood samples.